Co-Chair: Monica Morris, MSc, RN – Myeloma UK
Co-Chair: Ioanna Tsatsou
Co-Chair: Monica Morris, MSc, RN – Myeloma UK
Co-Chair: Ioanna Tsatsou
Speaker: Evangelos Terpos, MD, PhD (he/him/his) – Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Greece
Speaker: Gordon Cook, PhD – Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK
Speaker: Jessica Chen, MS, FNP – MD Anderson Cancer Center
Speaker: Donna D. Catamero, ANP-BC – Mount Sinai Hospital
Speaker: Chloe Ray, AGPCNP-BC, OCN – Mount Sinai Hospital
Co-Chair: Beth Faiman, PhD, MSN, APN-BC,BMTCN, AOCN, FAAN, FAPO – Cleveland Clinic Taussig Cancer Institute, Department of Hematology and Medical Oncology
Co-Chair: Matthias Hellberg-Naegele, MSc – Comprehensive Cancer Center Zurich
Speaker: Orla McCourt, PhD MCSP – University College London NHS Foundation Trust
Speaker: Joanne S. Land, BSc (she/her/hers) – NHS University College London Hospital, London, United Kingdom
Speaker: Emma Dowling, RN BSC – HCA Healthcare UK
Speaker: Houry Leblebjian
Speaker: Charise Gleason, NP-C – Winship Cancer Institute of Emory University
Co-Chair: Tiffany Richards
Co-Chair: Andrea D. Preston, MRPharmS (Consultant) (she/her/hers) – NHS / Sanius Health
Speaker: Tracy King, PhD, MN, RN – Royal Prince Alfred Hospital, The University of Sydney
Speaker: Monica Morris, MSc, RN – Myeloma UK
Speaker: Urvi A. Shah, MD (she/her/hers) – Myeloma Service, Memorial Sloan Kettering Cancer Center
Speaker: Rebecca Lu, MSN, FNP-C – MD Anderson
Speaker: Tracy King, PhD, MN, RN – Royal Prince Alfred Hospital, The University of Sydney